CoChat
Sign Up
Cited by 51

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

TBCK Influences Cell Proliferation, Cell Size and mTOR Signaling Pathway

Liu, Yueli, Yan, Xiaoyi, Zhou, Tianhua·2013·PLoS ONE
DOI 10.1371/journal.pone.0071349PMC PMC3747267
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0071349

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of TBCK. (A) Schematic comparison of TBCK homologs in H. sapiens, M. musculus, D. rerio, D. melanogaster, and C. elegans. Red, green and blue bars indicate possible kinase domain, TBC domain and rhodanese homology domain, respectively. (B) Expression of TBCK in mammalian cell lines. Total lysates from the indicated cells were resolved by SDS-PAGE and subjected to Western analysis. (C) Subcellular localization of TBCK. HEK293 cells grown on cover slides were immunostained with the antibodies as shown. DNA was visualized by DAPI. Bar, 10 μm.
Figure 1 Characterization of TBCK. (A) Schematic comparison of TBCK homologs in H. sapiens, M. musculus, D. rerio, D. melanogaster, and C. elegans. Red, green and blue bars indicate possible kinase domain, TBC domain and rhodanese homology domain, respectively. (B) Expression of TBCK in mammalian cell lines. Total lysates from the indicated cells were resolved by SDS-PAGE and subjected to Western analysis. (C) Subcellular localization of TBCK. HEK293 cells grown on cover slides were immunostained with the antibodies as shown. DNA was visualized by DAPI. Bar, 10 μm.CC BY · PubMed Central
Figure 2 Depletion of TBCK inhibits cell proliferation. HEK293 cells infected with the lentiviruses targeting to the various regions of TBCK mRNA (TBCK-RNAi-1 or 2) were subjected to Western blotting (A), cell counts (B), fluorescence microscopy (C) and MTT analyses (D). Bar, 200 µm. Lentivirus-infected cells were GFP-positive. Data are shown as the mean of three independent experiments ± SE (* P<0.05, ** P<0.01).
Figure 2 Depletion of TBCK inhibits cell proliferation. HEK293 cells infected with the lentiviruses targeting to the various regions of TBCK mRNA (TBCK-RNAi-1 or 2) were subjected to Western blotting (A), cell counts (B), fluorescence microscopy (C) and MTT analyses (D). Bar, 200 µm. Lentivirus-infected cells were GFP-positive. Data are shown as the mean of three independent experiments ± SE (* P<0.05, ** P<0.01).CC BY · PubMed Central
Figure 3 TBCK depletion reduces cell size. HEK293 cells were infected with the indicated lentivirus and subjected to fluorescence microscopy (A–B) and FACS analysis (C–D). (A–B) GFP-positive signals indicate the cells infected by lentivirus. Bar, 20 µm. The area measurements of infected cells were quantified by Image-Pro Plus 6.0 software. Data are shown as the mean of three independent experiments ± SE (** P<0.01, n>200). (C–D) Representative histogram of flow cytometry shows the size distribution (FSC-H) of GFP positive cells that were stained with propidium iodide. The mean of three independent experiments ± SE is shown (* P<0.05, n>100,000).
Figure 3 TBCK depletion reduces cell size. HEK293 cells were infected with the indicated lentivirus and subjected to fluorescence microscopy (A–B) and FACS analysis (C–D). (A–B) GFP-positive signals indicate the cells infected by lentivirus. Bar, 20 µm. The area measurements of infected cells were quantified by Image-Pro Plus 6.0 software. Data are shown as the mean of three independent experiments ± SE (** P<0.01, n>200). (C–D) Representative histogram of flow cytometry shows the size distribution (FSC-H) of GFP positive cells that were stained with propidium iodide. The mean of three independent experiments ± SE is shown (* P<0.05, n>100,000).CC BY · PubMed Central
Figure 4 TBCK plays a role in actin organization. HEK293 cells infected with the indicated lentivirus were subjected to immunofluorescence staining with phalloidin-TRITC (A) or anti-α-tubulin antibody (C). Lentivirus-infected cells were GFP-positive. DNA was visualized by DAPI. Bar, 10 µm. Single panel image of phalloidin-TRITC signal (B) or α-tubulin (D) is showed in rainbow palettes.
Figure 4 TBCK plays a role in actin organization. HEK293 cells infected with the indicated lentivirus were subjected to immunofluorescence staining with phalloidin-TRITC (A) or anti-α-tubulin antibody (C). Lentivirus-infected cells were GFP-positive. DNA was visualized by DAPI. Bar, 10 µm. Single panel image of phalloidin-TRITC signal (B) or α-tubulin (D) is showed in rainbow palettes.CC BY · PubMed Central
Figure 5 Depletion of TBCK influences mTOR signaling pathway. HEK293 cells were infected with the indicated lentivirus and subjected to Western blotting (A) and immunofluorescence analysis (B–C) with the antibodies as shown. GFP-positive signals indicate the cells infected by lentivirus. DNA was visualized by DAPI. Bar, 10 µm.
Figure 5 Depletion of TBCK influences mTOR signaling pathway. HEK293 cells were infected with the indicated lentivirus and subjected to Western blotting (A) and immunofluorescence analysis (B–C) with the antibodies as shown. GFP-positive signals indicate the cells infected by lentivirus. DNA was visualized by DAPI. Bar, 10 µm.CC BY · PubMed Central
Figure 6 TBCK influences the protein level of mTOR components and the activities of mTOR complexes. (A–B) HEK293 cells infected with the indicated lentivirus were subjected to immunoblotting with the antibodies as shown.
Figure 6 TBCK influences the protein level of mTOR components and the activities of mTOR complexes. (A–B) HEK293 cells infected with the indicated lentivirus were subjected to immunoblotting with the antibodies as shown.CC BY · PubMed Central
Figure 7 Depletion of TBCK represses the mRNA level of mTOR complexes components. Total RNAs from HEK293 cells infected with the indicated lentivirus were analyzed by quantitative RT-PCR with the targeted genes as shown. Error bars indicate SE (** P<0.01).
Figure 7 Depletion of TBCK represses the mRNA level of mTOR complexes components. Total RNAs from HEK293 cells infected with the indicated lentivirus were analyzed by quantitative RT-PCR with the targeted genes as shown. Error bars indicate SE (** P<0.01).CC BY · PubMed Central
Figure 8 TBCK has no significant effect on MAPK and PDK1/AKT pathway. (A–B) HEK293 cells infected with the indicated lentivirus were subjected to Western blotting with the antibodies as shown.
Figure 8 TBCK has no significant effect on MAPK and PDK1/AKT pathway. (A–B) HEK293 cells infected with the indicated lentivirus were subjected to Western blotting with the antibodies as shown.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 49

  1. T Schmelzle, 2000, TOR, a central controller of cell growth, Cell, 103, 253, 10.1016/S0092-8674(00)00117-3 · DOI
  2. S Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
  3. N Hay, 2004, Upstream and downstream of mTOR, Genes Dev, 18, 1926, 10.1101/gad.1212704 · DOI · Paper page
  4. R Loewith, 2011, Target of rapamycin (TOR) in nutrient signaling and growth control, Genetics, 189, 1177, 10.1534/genetics.111.133363 · DOI
  5. J Kim, 2011, Amino acid signaling in TOR activation, Annu Rev Biochem, 80, 1001, 10.1146/annurev-biochem-062209-094414 · DOI
  6. M Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017 · DOI · Paper page
  7. DH Kim, 2003, GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR, Mol Cell, 11, 895, 10.1016/S1097-2765(03)00114-X · DOI
  8. TR Peterson, 2009, DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival, Cell, 137, 873, 10.1016/j.cell.2009.03.046 · DOI · Paper page
  9. T Kaizuka, 2010, Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly, J Biol Chem, 285, 20109, 10.1074/jbc.M110.121699 · DOI
  10. K Hara, 2002, Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action, Cell, 110, 177, 10.1016/S0092-8674(02)00833-4 · DOI
  11. DH Kim, 2002, mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery, Cell, 110, 163, 10.1016/S0092-8674(02)00808-5 · DOI
  12. L Wang, 2007, PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding, J Biol Chem, 282, 20036, 10.1074/jbc.M702376200 · DOI
  13. K Thedieck, 2007, PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis, PLoS One, 2, e1217, 10.1371/journal.pone.0001217 · DOI
  14. E Vander Haar, 2007, Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40, Nat Cell Biol, 9, 316, 10.1038/ncb1547 · DOI
  15. E Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive, Nat Cell Biol, 6, 1122, 10.1038/ncb1183 · DOI
  16. DD Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Curr Biol, 14, 1296, 10.1016/j.cub.2004.06.054 · DOI · Paper page
  17. MA Frias, 2006, mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s, Curr Biol, 16, 1865, 10.1016/j.cub.2006.08.001 · DOI
  18. E Jacinto, 2006, SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity, Cell, 127, 125, 10.1016/j.cell.2006.08.033 · DOI
  19. LR Pearce, 2007, Identification of Protor as a novel Rictor-binding component of mTOR complex-2, Biochem J, 405, 513, 10.1042/BJ20070540 · DOI
  20. LR Pearce, 2011, Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney, Biochem J, 436, 169, 10.1042/BJ20102103 · DOI
  21. C Oneyama, 2011, MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways, Oncogene, 30, 3489, 10.1038/onc.2011.63 · DOI
  22. D Li, 2011, MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma, J Biol Chem, 286, 36677, 10.1074/jbc.M111.270561 · DOI
  23. Y Fang, 2012, MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma, Hepatology, 55, 1852, 10.1002/hep.25576 · DOI
  24. J Hou, 2011, Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma, Cancer Cell, 19, 232, 10.1016/j.ccr.2011.01.001 · DOI
  25. G Liu, 2012, Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury, Exp Neurol, 233, 447, 10.1016/j.expneurol.2011.11.018 · DOI
  26. F Fornari, 2010, MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells, Cancer Res, 70, 5184, 10.1158/0008-5472.CAN-10-0145 · DOI
  27. KR Leite, 2011, MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer, J Urol, 185, 1118, 10.1016/j.juro.2010.10.035 · DOI
  28. T Iwaya, 2012, Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway, Carcinogenesis, 33, 2391, 10.1093/carcin/bgs288 · DOI
  29. J Faridi, 2003, Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation, Am J Physiol Endocrinol Metab, 285, E964, 10.1152/ajpendo.00239.2003 · DOI
  30. G Manning, 2002, The protein kinase complement of the human genome, Science, 298, 1912, 10.1126/science.1075762 · DOI · Paper page
  31. C Greenman, 2007, Patterns of somatic mutation in human cancer genomes, Nature, 446, 153, 10.1038/nature05610 · DOI
  32. SK Hanks, 1995, Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification, FASEB J, 9, 576, 10.1096/fasebj.9.8.7768349 · DOI
  33. J Boudeau, 2006, Emerging roles of pseudokinases, Trends Cell Biol, 16, 443, 10.1016/j.tcb.2006.07.003 · DOI
  34. ED Scheeff, 2009, Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site, Structure, 17, 128, 10.1016/j.str.2008.10.018 · DOI
  35. AH Hutagalung, 2011, Role of Rab GTPases in membrane traffic and cell physiology, Physiol Rev, 91, 119, 10.1152/physrev.00059.2009 · DOI · Paper page
  36. MA Frasa, 2012, Illuminating the functional and structural repertoire of human TBC/RABGAPs, Nat Rev Mol Cell Biol, 13, 67, 10.1038/nrm3364 · DOI
  37. F Barr, 2010, Rab GEFs and GAPs, Curr Opin Cell Biol, 22, 461, 10.1016/j.ceb.2010.04.007 · DOI
  38. X Pan, 2006, TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanism, Nature, 442, 303, 10.1038/nature04847 · DOI
  39. T Itoh, 2006, Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity, Genes Cells, 11, 1023, 10.1111/j.1365-2443.2006.00997.x · DOI
  40. CC Dibble, 2012, TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1, Mol Cell, 47, 535, 10.1016/j.molcel.2012.06.009 · DOI · Paper page
  41. N Sato, 2010, Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis, Genes Chromosomes Cancer, 49, 353, 10.1002/gcc.20747 · DOI
  42. A Nakashima, 2007, Identification of TBC7 having TBC domain as a novel binding protein to TSC1–TSC2 complex, Biochem Biophys Res Commun, 361, 218, 10.1016/j.bbrc.2007.07.011 · DOI
  43. G Robertson, 2006, cisRED: a database system for genome-scale computational discovery of regulatory elements, Nucleic Acids Res, 34, D68, 10.1093/nar/gkj075 · DOI
  44. J Kong, 2012, Translational control in cellular and developmental processes, Nat Rev Genet, 13, 383, 10.1038/nrg3184 · DOI
  45. G Grillo, 2010, UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs, Nucleic Acids Res, 38, D75, 10.1093/nar/gkp902 · DOI
  46. S Sakakibara, 1996, Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell, Dev Biol, 176, 230, 10.1006/dbio.1996.0130 · DOI
  47. H Okano, 2002, Musashi: a translational regulator of cell fate, J Cell Sci, 115, 1355, 10.1242/jcs.115.7.1355 · DOI
  48. D Bordo, 2002, The rhodanese/Cdc25 phosphatase superfamily. Sequence-structure-function relations, EMBO Rep, 3, 741, 10.1093/embo-reports/kvf150 · DOI
  49. K Hofmann, 1998, A model of Cdc25 phosphatase catalytic domain and Cdk-interaction surface based on the presence of a rhodanese homology domain, J Mol Biol, 282, 195, 10.1006/jmbi.1998.1998 · DOI

Cited by

Sorted by citations

Metadata

Authors
Liu, Y., Yan, X., & Zhou, T.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2013-08-19
Volume
8
Issue
8
Pages
e71349
ISSN
1932-6203
DOI
10.1371/journal.pone.0071349
PMC
PMC3747267
Cited by
51
References
3
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review